Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS

AIDS Patient Care and STDs

Volumn 23, Issue 6, 2009, Pages 449-454

  Kalichman, Seth C ^a   Amaral, Christina M ^a   White, Denise ^a   Swetsze, Connie ^a   Pope, Howard ^a   Kalichman, Moira O ^a   Cherry, Chauncey ^a   Eaton, Lisa ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG INTOXICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; UNSPECIFIED SIDE EFFECT;

ALCOHOL DRINKING; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; DRUG INTERACTIONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; PREVALENCE; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS;

EID: 67651158958     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0184     Document Type: Article

References (18)

1. Bangsberg DR, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep 2007; 4: 65-72.
2. Parienti JJ, Das-Douglas M, Massari V, et al. Not all missed doses are the same: Sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE 2008; 3: e2783.
3. Chesney M. Adherence to HAART Regimens. AIDS Patient Care STDs 2003; 17: 169-177.
4. Berg CJ, Michelson SE, Safren SA. Behavioral aspects of HIV care: adherence, depression, substance use, and HIVtransmission behaviors. Infect Dis Clin North Am 2007; 21: 181-200.
5. Braithwaite RS, McGinnis KA, Conigliaro J, et al. A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism Clin Exp Res 2005; 29: 190-197.
6. Braithwaite RS, Conigliaro J, McGinnis KA, Maisto SA, Bryant K, Justice AC. Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res 2008; 32: 1645-1651.
7. Altice F, Mostashari F, Friedland G. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquire Immune Defic Syndr 2001; 28: 47-58.
8. Samet JH, Horton NJ, Traphagen ET, Lyon, SM, Freedberg KA. Alcohol consumption and HIV disease progression: Are they related? Alcoholism Clin Exp Res 2003; 27: 862-867.
9. Sankar A, Wunderlich T, Neufeld S, Luborsky M. Seropositive African Americans' beliefs about alcohol and their Impact on anti-retroviral adherence. AIDS Behav 2007; 11: 195-203.
10. Kalichman SC, Amaral C, Cherry C, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone Reliability and criterion-related validity. HIV Clin Trials 2008; 9: 298-308.
11. Saunders JB, Aasland OG, Babor TF, DeLaFuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addictions 1992; 88: 791-804.
12. Schmidt A, Barry K, Fleming M. Detection of problem drinkers: The Alcohol Use Disorders Test (AUDIT). Southern Med J 1995; 68: 52-59.
13. Bangsberg DR. Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS Behav 2001; 5: 275-281.
14. Kalichman SC, Amaral CM, Stearns H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. J Gen InternMed 2007; 22: 1003-1006.
15. Weinhardt L, Carey MP. Does alcohol lead to sexual risk behavior? Ann Rev Sex Res 2001; 12: 25-157.
16. Bangsberg D. Less Than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006; 43: 939-941.
17. Shuter J. Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother 2008; 61: 769-773.
18. Halkitis P, Palamar J, Mukherjee P. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling. AIDS Patient Care STDs 2008; 22: 323-335.